Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Abstract Text:

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: American journal of nephrology

VOLUME: 28

Page Numbers: 974-81

Journal Abbreviation: Am. J. Nephrol.

ISSN: 1421-9670

DAY: 9

MONTH: 07

YEAR: 2008

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8109361

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.

AFFILIATION:

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am J Nephrol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation Related Publications

• A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy.
• Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.
• Alteration of mRNA expression of molecules related to iron metabolism in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients on treatment.
• Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats.
• CENP-O Class Proteins Form a Stable Complex and Are Required for Proper Kinetochore Function.
• Down-regulation of manganese-superoxide dismutase through phosphorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats.
• Dynamic behavior of Nuf2-Hec1 complex that localizes to the centrosome and centromere and is essential for mitotic progression in vertebrate cells.
• Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.
• Protein and energy interactions throughout life. Metabolic basis and nutritional implications.
• Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients.
• Putative role of endothelial lipase in dialysis patients with hypoalbuminemia and inflammation.
• Serum Pro-hepcidin as an Indicator of Iron Status in Dialysis Patients.
• Spontaneous remission of severe hyperparathyroidism with normalization of the reversed whole PTH/intact PTH ratio in a haemodialysis patient.
• The kinetochore and spindle checkpoint in vertebrate cells.
• Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
• Whole or fragmentary information on parathyroid hormone?
• [Basic and Clinical Aspects of Calcimimetics. Calcimimetics : a promising treatment for persistent hypercalcemia after kidney transplantation.]
• [Basic and Clinical Aspects of Calcimimetics. Cinacalcet, effect and mechanisms of action.]
• [Basic and Clinical Aspects of Calcimimetics. Treatment of secondary hyperparathyroidism in dialysis patients with calcimimetics.]
• [The metabolic syndrome and bone health. The Relationship Between Lipid and Glucose Metabolism and Bone Mineral Metabolism : Pleiotropic effects of therapeutic agents for diabetes and hyperlipidemia.]